UX-DA-001

人中脑多巴胺能神经前体细胞（跃赛生物）

Report date: 2026/05/18 20:02:07

Base Information

Drug NameUX-DA-001
Drug Alias NameHuman midbrain dopaminergic progenitor cells injection人中脑多巴胺能神经前体细胞UX-DA001UX-DA-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionDopaminergic cell replacements
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Unixell Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Unixell Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A